Quantify

Abbott Laboratories vs Medtronic plc. — Stock Comparison

Abbott Laboratories (ABT) and Medtronic plc. (MDT) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

ABT
Abbott Laboratories
$87.41
▼ 0.41%
vs
MDT
Medtronic plc.
$78.60
▲ 0.58%
Q·Score Winner
Abbott Laboratories
ABT7.1/10vs 7/10

Abbott Laboratories narrowly edges Medtronic plc. on Q·Score (7.1 vs 7 out of 10), led by Sentiment (7.7 vs 6.6) and Quality (7.7 vs 6.7). Medtronic plc. scores higher on Health, reflecting stronger balance sheet strength. Analyst price targets imply similar upside for both: +35.7% for ABT and +36.2% for MDT.

Q·Score Breakdown

7.1
Bullish
Overall
7
Bullish
7.7
Quality
6.7
7
Health
7.9
4.7
Growth
5.6
8.6
Valuation
8.1
7.7
Sentiment
6.6
ABT

Consensus analyst target of $118.64 is 36% above current price.

⚠ earnings contracting 20% year-over-year.

MDT

Consensus analyst target of $107.08 is 36% above current price.

Analyst Consensus

Bullish
+35.7%
Target $118.64
25 analysts
Bullish
+36.2%
Target $107.08
26 analysts

Fundamentals

ABT
MDT
24.5×
Trailing P/E
22.0×
14.4×
Forward P/E
13.0×
13.90%
Profit Margin
13.00%
56.50%
Gross Margin
65.16%
12.33%
ROE
9.39%
7.80%
Revenue Growth
8.70%
-19.70%
Earnings Growth
-11.80%
0.65
Beta
0.63
2.88%
Dividend Yield
3.61%
$152.3B
Market Cap
$100.9B
52-Week Range
ABT
$8210% of range$139
MDT
$7413% of range$106

Frequently Asked Questions

ABT vs MDT: which stock scores better overall?

Based on Q·Score, Abbott Laboratories (ABT) scores 7.1/10 versus Medtronic plc. (MDT) at 7/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: ABT or MDT?

Medtronic plc. (MDT) scores higher on Growth (5.6/10 vs 4.7/10). Abbott Laboratories reports revenue growth (7.8% YoY) while Medtronic plc. reports (8.7% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is ABT or MDT more attractively valued?

Abbott Laboratories (ABT) scores higher on Valuation (8.6/10 vs 8.1/10). ABT trades at 14.4× P/E versus MDT at 13.0×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about ABT vs MDT?

There are 25 analysts covering ABT with a consensus price target of $118.64, and 26 analysts covering MDT with a consensus target of $107.08. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: ABT or MDT?

Abbott Laboratories (ABT) scores higher on Quality (7.7/10 vs 6.7/10). Net profit margin: ABT at 13.9%, MDT at 13.0%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: ABT or MDT?

Medtronic plc. (MDT) scores higher on Financial Health (7.9/10 vs 7/10). Market beta: ABT at 0.65, MDT at 0.63. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of ABT and MDT?

Abbott Laboratories (ABT) has a market capitalisation of $152.3B, while Medtronic plc. (MDT) has a market cap of $100.9B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Do ABT or MDT pay dividends?

ABT pays a dividend yield of 2.88%, while MDT pays a dividend yield of 3.61%. Dividend yields fluctuate with share price and company payout decisions.

Related Comparisons

ISRG vs MDTABT vs ISRG

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026